Mark A. Rothstein

Institute for Clinical and Translational Science, University of California Irvine

Mark A. Rothstein is Director of Translational Bioethics at the Institute for Clinical and Translational Science, University of California, Irvine.

Before assuming his present position in 2023, he was Herbert F. Boehl Chair of Law and Medicine and Director of the Institute for Bioethics, Health Policy and Law at the University of Louisville School of Medicine (2001-2022) and Hugh Roy and Lillie Cranz Cullen Distinguished Professor Law and Director of the Health Law and Policy Institute at the University of Houston Law Center (1986-2000).

Professor Rothstein’s current research interests include genetics, health privacy, international research ethics, public health, and translational bioethics. He is a past president of the American Society of Law, Medicine and Ethics, an elected member of the American Law Institute, and an elected fellow of the Hastings Center.

Since 2023, he is Contributing Editor of the “Ethics in Translational Research” column in Ethics & Human Research. From 2003-2023, he wrote a regular column, “Currents in Contemporary Bioethics,” for the Journal of Law, Medicine and Ethics. From 2011-2019, he was Associate Editor for Public Health Ethics and Law of the American Journal of Public Health.

Professor Rothstein is the author or editor of 19 books and over 350 book chapters and articles.

He received a B.A. from the University of Pittsburgh and a J.D. from Georgetown University.

Presentation (in PowerPoint format): International Perspectives on the Scope of Biomedical Research Ethics and Law